Inhaled corticosteroids (ICS) are the mainstay of treatment for asthma, but their role in
chronic obstructive pulmonary disease (COPD) is debated. Recent randomised controlled …

The European Respiratory Society journals publish respiratory research and policy
documents of the highest quality, offering a platform for the exchange and promotion of …

Background Inhaled corticosteroids (ICS) are indicated for prevention of exacerbations in
patients with COPD, but they are frequently overprescribed. ICS withdrawal has been …

Although pharmacological treatment of COPD is codified in different guidelines and strategy
documents, there is abundant evidence of discrepancy between what they suggest and what …

Background Chronic obstructive pulmonary disease (COPD) are managed predominantly in
primary care. However, key opportunities to optimize treatment are often not realized due to …

Blood eosinophil counts have emerged as a chronic obstructive pulmonary disease (COPD)
biomarker that predict the effects of inhaled corticosteroids (ICS) in clinical practice. Post-hoc …

The right treatment for the right patient with COPD: lessons from the IMPACT trial |
European Respiratory Society Skip to main content Main menu Home Current issue ERJ …

Introduction Chronic obstructive pulmonary disease (COPD) is one of the main causes of
death and disability worldwide. Many treatment options are now available, but criteria for …

Purpose: This real-world study evaluated the effectiveness of different inhalation therapies in
patients with symptomatic chronic obstructive pulmonary disease (COPD) in China and also …

BACKGROUND: Severe exacerbations requiring hospitalization contribute a substantial
portion of the morbidity and costs of chronic obstructive pulmonary disease (COPD). Triple …